This inventor holds 4 USPTO granted patents and 1 published patent application. Top assignees: Harvard College, The General Hospital Corporation. Active years: 2024-2026.
Company Filing History:
4 out of 3,069 
1 out of 3,068 
Years Active: 2024-2026
Title: The Innovations of Eric Kelsic
Introduction
Eric Kelsic is an accomplished inventor based in Cambridge, MA. He has made significant contributions to the field of gene delivery through his innovative research and patents. His work focuses on enhancing the capabilities of viral vectors for improved gene therapy applications.
Latest Patents
Eric Kelsic holds a patent for "Viral vectors exhibiting improved gene delivery properties." This technology provides viral capsid polypeptides that bear mutations, altering the tissue tropism of a virus. The patent describes various embodiments where the tissue tropism can be modified to target the heart, kidney, liver, lung, spleen, or blood.
Career Highlights
Kelsic's career is marked by his dedication to advancing gene therapy technologies. His work at Harvard College has positioned him as a key figure in the research community, contributing to the understanding and application of viral vectors in medicine.
Collaborations
Eric Kelsic has collaborated with notable scientists, including George M. Church and Pierce Ogden. These partnerships have further enriched his research and expanded the impact of his innovations in the field.
Conclusion
Eric Kelsic's contributions to gene delivery technology exemplify the potential of innovative research in medicine. His patent and collaborations highlight the importance of advancing therapeutic techniques for better health outcomes.